Paramasivam M. Arumugam - Publications

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer.

Journal: Journal of oral biology and craniofacial research

Published: November 01, 2025

High expression of TRMT112 is associated with the development of oral squamous cell carcinoma.

Journal: Journal of oral biology and craniofacial research

Published: October 04, 2025

SND1, a novel m6A RNA regulator: Its high expression correlates with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.

Journal: Journal of oral biology and craniofacial research

Published: May 23, 2025

High Expression of CHD1L, a Potent Oncogene Is Associated With Aggressive Head and Neck Cancer and Poor Survival Outcome.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: November 11, 2024

Triggering Receptor Expression on Myeloid Cells-1 (TREM1) Promoter Hypomethylation and Its Overexpression Associated With Poor Survival of Cancer Patients: A Pan-Cancer Analysis.

Journal: Cureus

Published: April 15, 2024

Altered gene expression profile in human gingival keratinocytes treated with Aggregatibacter actinomycetemcomitans and their role in the development of head and neck squamous cell carcinoma.

Journal: Dental and medical problems

Published: January 09, 2024

Amplification and overexpression of a novel m6A reader FXR1 are associated with poor prognosis in head and neck squamous cell carcinoma.

Journal: Dental and medical problems

Published: January 08, 2024

Overexpression of insulin-like growth factor-2 mRNA-binding protein 1 is associated with periodontal disease.

Journal: Journal of oral biology and craniofacial research

Published: January 05, 2024

MicroRNAs targeting CDKN2A gene as a potential prognostic marker in head and neck squamous cell carcinoma.

Journal: Molecular biology research communications

Published: January 02, 2024

The novel m6A writer methyltransferase 5 is a promising prognostic biomarker and associated with immune cell infiltration in oral squamous cell carcinoma.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: December 16, 2023

Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy.

Journal: Epigenomics

Published: November 22, 2023

Genetic association between rs1695 in glutathione S-transferase P1 and risk of periodontitis: a pilot study.

Journal: Molecular biology research communications

Published: October 27, 2023